Rite Aid and Heritage Provider Network last month announced a new agreement to bring the Rite Aid Health Alliance program to HPN's chronic and polychronic patients in Southern California.
LIU Pharmacy, part of the Arnold and Marie Schwartz College of Pharmacy and Health Sciences, announced that educator and researcher Dr. John Pezzuto has been named dean of the LIU Pharamacy, effective Jan. 1, 2015.
Greenstone, a U.S.-based subsidiary of Pfizer, announced the introduction of doxazosin mesylate tablets.
At Google’s I/O Developer Conference last month, MediSafe expanded its medication management platform to include wearables, becoming the first mobile health app on Google’s just-announced suite of Android Wear smartwatches, the company announced Tuesday.
Purdue Pharma on Tuesday announced that the Food and Drug Administration has granted priority review designation for the company's once-daily, single-entity hydrocodone bitartrate tablet.
Rexam Prescription Products on Tuesday is changing its name to Centor, the company announced.
Mylan announced the launch of telmisartan tablets USP, which is used to treat hypertension.
Novo Nordisk on Monday announced that the Food and Drug Administration approved the company's NovoSeven RT (coagulation factor VIIa [recombinant]).
Sandoz announced the launch of valsartan tablets, an authorized generic version of Diovan tablets which is used for the treatment of high blood pressure.
According to a report from the American Academy of Family Physicians, the Advisory Committee on Immunization Practices for the Centers for Disease Control and Prevention voted unanimously to recommend that healthy children between the ages of 2 years and 8 years be inoculated with a live attenuated influenza vaccine like FluMist, as opposed to the traditional flu shot.